Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Combined with Adjuvant Chemotherapy in Gastric Cancer
NCT03607656Phase 3Completed
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Jun 2018
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoint: 3-year Disease Free Survival rate. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03607656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607656.